The study aims to review the validity of CSF proteins (α-synuclein and DJ-1) as effective biomarkers in the early detection of Parkinsonism and the novel proteomic techniques directed toward the detection of several undifferentiated proteins in CSF. Here, PARK7 is linked to Parkinson disease.